Here is a new trial, different from the NIH one but that also targets NY-ESO-1:
http://www.roswellpark.org/media/news/roswell-park-launches-landmark-immunotherapy-vaccine-trial
Here is a new trial, different from the NIH one but that also targets NY-ESO-1:
http://www.roswellpark.org/media/news/roswell-park-launches-landmark-immunotherapy-vaccine-trial